Abstract: A method for determining the level of survival motor neuron (SMN) protein in a whole blood or cerebral spinal fluid (CSF) sample, for example, a whole blood lysate sample or a CSF sample, including obtaining a whole blood or cerebral spinal fluid (CSF) sample from the subject and conducting an electrochemiluminescence immunoassay to determine the level of SMN in the whole blood or cerebral spinal fluid (CSF) sample.
Type:
Application
Filed:
June 11, 2014
Publication date:
December 18, 2014
Applicant:
PharmOptima, LLC
Inventors:
Phillip Zaworski, Roger Poorman, Douglas Decker